3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
57
Prostatic Neoplasms, Castration-Resistant
4
Metastatic Castration-resistant Prostate Cancer
3
Prostate Cancer Metastatic
2
Neoplasm Metastasis
2
Metastatic Castration-Resistant Prostate Cancer
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stage II Prostate Adenocarcinoma
1
Sleep Initiation and Maintenance Disorders
1
Prostatic Diseases
1
Prostate Adenocarcinoma
1
Ovarian Neoplasms
1
Oligometastatic Prostate Carcinoma
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms by Site
1
Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone Refractory Prostate Cancer
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration Resistant Prostate Cancer
1
Male Urogenital Diseases
1
Genital Neoplasms, Male
1
Fatigue
1
Depression
1
Dementia
1
Cognitive Dysfunction
1
Carcinoma, Transitional Cell
1
Interventions
relacorilant
3
Osilodrostat
2
Metyrapone
2
Perceived Stress Scale
1
ASP3662
1
4-amino-4'-hydroxylaminodiphenylsulfone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cushing Syndrome
×
Abiraterone Acetate
×
1 year
×
Clear all
No trials found.